Henry Schein, Inc. filed a Form 8-K on November 16, 2026, disclosing a voluntary change to its non-GAAP financial measure presentation and a corresponding update to its full-year 2026 non-GAAP diluted earnings per share guidance.
Lithium Americas Corp. filed a current report on November 16, 2026, disclosing that on November 10, 2026, it entered into Omnibus Waiver, Consent and Amendment No. 3 with the U.S. Department of Energy and other parties, amending key agreements governing the DOE loan for …
OZ Vision Inc. filed a current report on November 16, 2026, disclosing that its Board of Directors concluded investors should no longer rely on the company's previously issued audited financial statements for the fiscal years ended June 30, 2025 and June 30, 2026, due …
Summit Therapeutics Inc. filed a Form 8-K on November 16, 2026, disclosing that the U.S. Food and Drug Administration issued a Complete Response Letter on November 15, 2026, regarding the Biologics License Application for ivonescimab in combination with platinum-containing chemotherapy for certain non-small cell …
Zymeworks Inc. filed an 8-K on November 16, 2026, disclosing that its Board of Directors authorized a second 2026 share repurchase program allowing the company to repurchase up to $200.0 million of its outstanding common stock through 2028.
Quality Industrial Corp. filed a Form 8-K on November 16, 2026, announcing the release of its financial results for the three and nine months ended September 30, 2026, alongside the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, …
XTI Aerospace, Inc. filed a Form 8-K on November 16, 2026, disclosing that Chief Operating Officer Michael A. Tapp resigned from his position effective immediately on November 9, 2026.
Vale S.A. filed a Form 6-K on November 13, 2026, disclosing that it will pay R$214,228,183.24 in remuneratory interest on its 11th issue incentive debentures on November 16, 2026.
Grupo Aval Acciones y Valores S.A. filed a Form 6-K with the SEC on November 16, 2026, reporting its consolidated financial results for the third quarter ended September 30, 2026.
Cosan S.A. filed a Form 6-K with the U.S. Securities and Exchange Commission for the month of November 2026, submitting its condensed interim financial statements for the quarter and nine-month period ended September 30, 2026, reviewed by PricewaterhouseCoopers Auditores Independentes Ltda.